Medically reviewed by Chandre Tina May, Registered Nurse & Menopause Society Certified Practitioner (MSCP). See our editorial policy.
If you have PCOS, chances are you’ve heard someone mention Ozempic — maybe in a waiting room, a Facebook group, or a conversation with a friend who swears it changed her life. And you’re probably wondering: could this actually help me? Or is it just another thing that works for everyone except women whose bodies are already this complicated?
You’re asking the right questions. PCOS and Ozempic (the brand name for semaglutide, a type of GLP-1 drug) are being talked about together a lot right now — and the connection is more than hype. But it’s also not a simple story. This article will explain what GLP-1 drugs actually do, why they’re relevant to PCOS specifically, what the emerging evidence shows, and what’s still genuinely unknown, so you can have a real conversation with your doctor rather than walking in with half a picture.
What’s Actually Happening: PCOS, Insulin, and the Communication Breakdown
Think of insulin as a messenger — it knocks on the door of your cells and says, “let this sugar in.” In many women with PCOS, those cells have started ignoring the knock. The messenger keeps sending more and more signals, but the doors stay shut. This is insulin resistance, and it’s present in an estimated 65–70% of women with PCOS, according to research cited by Verity (the UK PCOS charity).
When insulin signals are stuck in a loop like this, the body compensates by flooding the system with even more insulin. High insulin levels then tell the ovaries to produce more androgens (male hormones), which drives many of the most frustrating PCOS symptoms: irregular periods, acne, hair thinning on the scalp, and unwanted hair growth elsewhere.
GLP-1 (glucagon-like peptide-1) is a hormone your gut naturally produces after you eat. It does several things: it prompts your pancreas to release insulin in a measured, glucose-dependent way, slows how quickly food leaves your stomach, and signals to the brain that you’re full. GLP-1 receptor agonist drugs — including semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda) — mimic and amplify this communication. They don’t force insulin out; they help the whole system talk more clearly again.
For women with PCOS, where faulty insulin communication is often at the root of so many symptoms, that’s a meaningful distinction.
What the Evidence Actually Shows
GLP-1 drugs were originally developed for type 2 diabetes and are licensed for that use. Wegovy (higher-dose semaglutide) is also now licensed for weight management in many countries. Their use specifically for PCOS is currently off-label — meaning doctors can prescribe them for this purpose, but it’s not a listed indication, and the evidence base, while promising, is still building.
What small studies and clinical observations have shown so far includes:
- Improvements in insulin sensitivity — addressing the core communication problem in PCOS directly.
- Reductions in androgen levels in some women, which may improve cycle regularity, acne, and excess hair growth.
- Meaningful weight loss in women with PCOS who also have overweight or obesity — and even modest weight loss (5–10% of body weight) is associated with improved hormonal balance and restored ovulation, according to the NHS.
- Reduced inflammation markers — chronic low-grade inflammation is a recognised feature of PCOS, and GLP-1 drugs appear to have anti-inflammatory properties.
It’s worth noting that metformin — the long-established, low-cost medication already used widely in PCOS — also targets insulin resistance and has decades of safety data behind it. Some clinicians now see GLP-1 drugs as a next step when metformin isn’t tolerated or isn’t enough, rather than a replacement. If you’re curious about how different PCOS treatments compare and where to start, our guide to PCOS treatment options and what the evidence says breaks this down further.
What’s Still Unknown — and Why That Matters
Honest caveat time, because you deserve the full picture.
Most GLP-1 trials have been conducted in people with type 2 diabetes or obesity — not specifically in women with PCOS. The PCOS-specific studies so far are small and short-term. We don’t yet have large, long-term randomised controlled trials looking at GLP-1 drugs in PCOS populations. That doesn’t mean they don’t work — but it does mean the evidence is still maturing.
Side effects are also real and worth knowing about. Nausea, vomiting, and gut discomfort are the most common, particularly when starting treatment. Most women find these ease over time, but for some they’re significant enough to stop. There are also contraindications — these drugs are not suitable if you have a personal or family history of certain thyroid conditions, and they are not recommended during pregnancy. Since improving ovulation is a possible effect in women with PCOS, reliable contraception matters if pregnancy is not your goal right now.
Cost and access are a genuine barrier too. Outside of a type 2 diabetes diagnosis, these medications can be expensive and are not always covered by insurance or available on the NHS for PCOS specifically.
Understanding the full hormonal picture of your PCOS — not just insulin resistance, but also how androgens, your cycle, and inflammation interact — is important context before considering any new treatment. Our in-depth look at how PCOS affects hormones and what that means for your symptoms can help you build that foundation.
What Actually Helps: A Practical Overview
GLP-1 drugs sit within a wider toolkit. Here’s how the options stack up:
Lifestyle measures (always the starting point)
A lower-glycaemic diet, regular movement, and adequate sleep all improve insulin sensitivity directly. These aren’t about weight — they’re about helping the broken communication system work better. Even small, consistent changes have meaningful hormonal effects in PCOS.
Non-hormonal medications
Metformin remains the most evidence-backed insulin-sensitising medication for PCOS and is typically the first medical option considered. Inositol supplements (particularly myo-inositol) also have emerging evidence for improving insulin signalling and are available without prescription, though a clinician should guide use.
Hormonal treatments
The combined oral contraceptive pill, anti-androgens, and progesterone to regulate cycles are all established options for managing specific PCOS symptoms. They don’t fix insulin resistance but can address the hormonal consequences of it.
GLP-1 drugs
For women with PCOS who also have significant insulin resistance, overweight, or obesity — and particularly those who haven’t responded adequately to metformin — GLP-1 receptor agonists are increasingly being considered by clinicians. They are not a first-line treatment for PCOS at this stage, but they are a legitimate conversation to have. If you’re also managing weight as part of PCOS and wondering how to approach this with your doctor, our piece on weight, PCOS, and the things no one tells you may be useful alongside this one.
When to See a Doctor
Talk to your GP or a PCOS specialist if:
- You have PCOS with confirmed or suspected insulin resistance and your current management isn’t working well enough.
- You’re considering any GLP-1 medication — including those obtained privately or online. These drugs have real contraindications and require monitoring.
- You’re experiencing new or worsening symptoms — irregular cycles, significant unexplained weight gain, signs of high androgens — that feel unmanaged.
- You want to conceive and are unsure how a GLP-1 drug might interact with fertility.
If you’ve seen adverts or social media posts promoting GLP-1 drugs directly to consumers, be cautious. A proper assessment — including your full medical history — is essential before starting.
Frequently Asked Questions
Does Ozempic help with PCOS?
Early evidence suggests GLP-1 drugs like Ozempic may improve insulin resistance, reduce androgen levels, and support weight loss in women with PCOS. However, this use is currently off-label, the studies are small, and it’s not a first-line treatment. Speak to a doctor who knows your full PCOS picture before considering it.
Can I get Ozempic for PCOS on the NHS?
Currently, GLP-1 drugs are not routinely prescribed on the NHS for PCOS specifically. They may be available if you also have type 2 diabetes or meet criteria for weight management treatment. A PCOS specialist or endocrinologist can advise on what’s available to you.
Is Ozempic better than metformin for PCOS?
They work differently and aren’t directly comparable. Metformin has decades of evidence in PCOS, is low-cost, and is typically the first insulin-sensitising medication recommended. GLP-1 drugs may offer additional benefits — particularly for weight — but they are usually considered when metformin hasn’t been sufficient or isn’t tolerated.
Will a GLP-1 drug make my periods regular?
Possibly, for some women — particularly if irregular cycles are driven by insulin resistance and improved insulin sensitivity restores ovulation. But results vary, and cycle regulation is not guaranteed. This should be discussed with your clinician, especially if you are or aren’t trying to conceive.
Are GLP-1 drugs safe if I have PCOS?
For most women they appear well-tolerated, though nausea is common initially. There are important contraindications, including certain thyroid conditions. They’re not recommended during pregnancy. A thorough medical review before starting is essential — don’t start these medications without clinical supervision.
This article is for general information and is not medical advice. It was reviewed by a certified healthcare professional in line with our editorial policy, and we update our content as the science evolves — but every woman’s body is different, so please speak to a qualified healthcare professional about your own symptoms.